findmyKOL
Clinical trialNCT00795574CompletedPhase 2Interventional

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa

SponsorFlorida Academic Dermatology CentersEnrollment38Hidradenitis Suppurativa
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A study to assess the safety and efficacy of the IV drug infliximab for the treatment of hidradenitis suppurativa
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Academic Dermatology Center

    Miami, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo ComparatorInfliximab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2005
Primary completion
31 Aug 2008
Completion
31 Aug 2008
Last update posted
24 Nov 2008
Registered enrollment
38
Registry id
NCT00795574
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.